Big news: Syncozymes has an annual output of 100 tons of coenzyme NMN/NADH/NAD series. These ingredients will be put into production

Classification： Company News

Publication：2022-08-03 09:30

Syncozymes's annual production of 100 tons of coenzyme NMN/NADH/NAD series products will be officially put into production in October this year!

（Zhejiang Syncozymes Bio-pharmaceutical Co., Ltd.）

As the forerunner of domestic green biological enzyme catalysis technology, Syncozymes has invested 2 billion yuan in the "Bio-enzyme series products and chemical drug industry" on the basis of integrating the R&D and production advantages of the two major companies, Shangke (Shanghai) Biology and Supor Pharmaceuticals. the chemical based project is progressing

Previous: FDA approves ibrutinib for the treatment of chronic graft-versus-host disease ( cGVHD ) in children

Next: Big News! SyncoZymes (Shanghai) Co., Ltd , The world's first NMN raw material passed FDA NDI certification.

Leave a Message Online